abstract |
The present invention relates to compounds of formula I, Stereoisomers, enantiomers, pharmaceutically acceptable salts or amino acid conjugates thereof; wherein the variables are as defined herein; and the invention also relates to pharmaceutical compositions thereof for use as farnesol X receptors modulator of FXR activity. |